CIK 0001226616 · Non-accelerated filer<br>Smaller reporting company
MEDICINOVA INC
Sign in to watch- Ticker
- MNOV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330927979
- Phone
- 858-373-1500
- Business address
- 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,728,000
- in 1 filing
Net −$1,728,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-06 | Nagao Hideki Director | Option exercise | +15,000 | $2.58 | $39K | 16,000 |
| 2020-08-06 | Nagao Hideki Director | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2020-06-16 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-16 | Kobayashi Yutaka Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-12 | Matsuda Kazuko Chief Medical Officer | Option exercise | +20,000 | $5.13 | $103K | 160,192 |
| 2020-06-12 | Matsuda Kazuko Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2020-04-08 | Matsuda Kazuko Chief Medical Officer | Option exercise | +28,446 | $2.54 | $72K | 140,192 |
| 2020-04-08 | Matsuda Kazuko Chief Medical Officer | Option exercise · Employee Stock option (Right to Buy) | −28,446 | 46,554 | ||
| 2020-04-08 | IWAKI YUICHI President and CEO | Option exercise | +60,417 | $2.54 | $153K | 841,100 |
| 2020-04-08 | IWAKI YUICHI President and CEO | Option exercise · Employee Stock option (Right to Buy) | −60,417 | 39,583 | ||
| 2020-03-13 | Matsuda Kazuko Chief Medical Officer | Purchase | +2,000 | $3.62 | $7K | 111,746 |
| 2020-03-13 | Matsuda Kazuko Chief Medical Officer | Purchase | +2,000 | $3.62 | $7K | 111,476 |
| 2020-03-12 | IWAKI YUICHI President and CEO | Purchase | +20,000 | $3.10 | $62K | 780,683 |
| 2020-01-09 | OBrien Geoffrey Vice President | Grant or award · Employee Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2020-01-09 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +243,750 | 243,750 | ||
| 2020-01-09 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +412,500 | 412,500 | ||
| 2019-06-12 | Matsuda Kazuko Chief Medical Officer | Option exercise | +37,000 | $4.80 | $178K | 109,457 |
| 2019-06-12 | Matsuda Kazuko Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | +37,000 | 0 | ||
| 2019-06-10 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-06-10 | Kobayashi Yutaka Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 4 of 8 · 149 trades